- Thursday, August 3, 2023
8:00 AM – 8:15 AM ET
Welcome
8:00 AM – 8:15 AM ET
WelcomeCo-Chair: – Vanderbilt-Ingram Cancer Center
Co-Chair: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Co-Chair###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Co-Chair: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Co-Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Co-Chair: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### 8:15 AM – 8:30 AM ET
8 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided All RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Triplet Chemo + Bevacizumab
8:15 AM – 8:30 AM ET
Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided All RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Triplet Chemo + BevacizumabPresenter: – Fox Chase Cancer Center
Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Presenter###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Presenter: – Fox Chase Cancer Center
### 8:30 AM – 8:45 AM ET
8 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Doublet Chemo + Panitumumab
8:30 AM – 8:45 AM ET
Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Doublet Chemo + PanitumumabPresenter: – Department of Hematology and Oncology at Cleveland Clinic
Smitha Krishnamurthi, MD (she/her/hers) – Department of Hematology and Oncology at Cleveland Clinic ### 1691686###Presenter###Associate Professor###Department of Hematology and Oncology at Cleveland Clinic###Presenter: – Department of Hematology and Oncology at Cleveland Clinic
### she/her/hers8:45 AM – 9:00 AM ET
9 - Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - Discussion
8:45 AM – 9:00 AM ET
Session 8: Debate: Triplet Chemotherapy (FOLFOXIRI) + Bevacizumab vs Doublet Chemotherapy (FOLFOX/FOLFIRI) + Panitumumab for Left-sided all RAS Wild-Type Metastatic Colorectal Cancer (mCRC) - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: – Department of Hematology and Oncology at Cleveland Clinic
Panelist: – Fox Chase Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Smitha Krishnamurthi, MD (she/her/hers) – Department of Hematology and Oncology at Cleveland Clinic ### 1691686###Panelist###Associate Professor###Department of Hematology and Oncology at Cleveland Clinic###Panelist: – Department of Hematology and Oncology at Cleveland Clinic
### she/her/hers @@@ Namrata (Neena) Vijayvergia, MD, FACP – Fox Chase Cancer Center ### 1544845###Panelist###Assistant Chief, Gastrointestinal Medical Oncology; Associate Professor###Fox Chase Cancer Center###Panelist: – Fox Chase Cancer Center
### 9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
9:15 AM – 9:50 AM ET
Session 9: Integrating Biomarkers into the Management of Gastric Cancer: A Focus on Molecular Testing and Targeted Treatment Strategies
9:15 AM – 9:50 AM ET
Session 9: Integrating Biomarkers into the Management of Gastric Cancer: A Focus on Molecular Testing and Targeted Treatment StrategiesPresenter: – Memorial Sloan Kettering Cancer Center
Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Presenter###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center ### 1003985###Speaker###Chief, Gastrointestinal Oncology Service###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
### 10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
10:15 AM – 11:15 AM ET
Non-CME Innvoation Theater
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
11:30 AM – 12:05 PM ET
10 - Session 10: Therapeutic Sequencing in Advanced Colorectal Cancer: New Strategies from Clinical Trial DataPresenter: – University of Arizona Cancer Center
11:30 AM – 12:05 PM ET
Session 10: Therapeutic Sequencing in Advanced Colorectal Cancer: New Strategies from Clinical Trial DataPresenter: – University of Arizona Cancer Center
Aaron J. Scott, MD – University of Arizona Cancer Center ### 2027555###Presenter###Associate Professor###University of Arizona Cancer Center###Presenter: – University of Arizona Cancer Center
### 12:05 PM – 12:15 PM ET
10 - Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – University of Arizona Cancer Center
12:05 PM – 12:15 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – University of Arizona Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Aaron J. Scott, MD – University of Arizona Cancer Center ### 2027555###Speaker###Associate Professor###University of Arizona Cancer Center###Speaker: – University of Arizona Cancer Center
### 12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
12:30 PM – 1:05 PM ET
11 - Session 11: Updates from Recent MeetingsPresenter: – University Hospitals Leuven / KU Leuven
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent MeetingsPresenter: – University Hospitals Leuven / KU Leuven
Eric Van Cutsem, MD, PhD (he/him/his) – University Hospitals Leuven / KU Leuven ### 697455###Presenter###Professor of Medicine###University Hospitals Leuven / KU Leuven###Presenter: – University Hospitals Leuven / KU Leuven
### he/him/his1:05 PM – 1:15 PM ET
11 - Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – University Hospitals Leuven / KU Leuven
1:05 PM – 1:15 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – University Hospitals Leuven / KU Leuven
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Eric Van Cutsem, MD, PhD (he/him/his) – University Hospitals Leuven / KU Leuven ### 697455###Speaker###Professor of Medicine###University Hospitals Leuven / KU Leuven###Speaker: – University Hospitals Leuven / KU Leuven
### he/him/his1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
1:30 PM – 2:30 PM ET
Non-CME Innvoation Theater
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
2:45 PM – 3:00 PM ET
12 - Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRT
2:45 PM – 3:00 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - PRRTPresenter: – The University of Texas MD Anderson Cancer Center
Arvind Dasari, MD – The University of Texas MD Anderson Cancer Center ### 1428669###Presenter###Associate Professor###The University of Texas MD Anderson Cancer Center###Presenter: – The University of Texas MD Anderson Cancer Center
### 3:00 PM – 3:15 PM ET
12 - Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - Chemotherapy
3:00 PM – 3:15 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - ChemotherapyPresenter: – Huntsman Cancer Institute at the University of Utah
Heloisa Soares, MD, PhD (she/her/hers) – Huntsman Cancer Institute at the University of Utah ### 1880692###Presenter###Associate Professor###Huntsman Cancer Institute at the University of Utah###Presenter: – Huntsman Cancer Institute at the University of Utah
### she/her/hers3:15 PM – 3:30 PM ET
12 - Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy
3:15 PM – 3:30 PM ET
Session 12: Debate: Pancreatic NETs: PRRT vs Chemotherapy - DiscussionModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: – The University of Texas MD Anderson Cancer Center
Panelist: – Huntsman Cancer Institute at the University of Utah
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Arvind Dasari, MD – The University of Texas MD Anderson Cancer Center ### 1428669###Panelist###Associate Professor###The University of Texas MD Anderson Cancer Center###Panelist: – The University of Texas MD Anderson Cancer Center
### @@@ Heloisa Soares, MD, PhD (she/her/hers) – Huntsman Cancer Institute at the University of Utah ### 1880692###Panelist###Associate Professor###Huntsman Cancer Institute at the University of Utah###Panelist: – Huntsman Cancer Institute at the University of Utah
### she/her/hers3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
3:45 PM – 4:20 PM ET
13 - Session 13: The Pillars of Cancer Wellness
3:45 PM – 4:20 PM ET
Session 13: The Pillars of Cancer WellnessPresenter: – Memorial Sloan Kettering Cancer Center
Gary E. Deng, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1699641###Presenter###Medical Director, Integrative Medicine Service###Memorial Sloan Kettering Cancer Center###Presenter: – Memorial Sloan Kettering Cancer Center
### 4:20 PM – 4:30 PM ET
13 - Live Q&A
4:20 PM – 4:30 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – Memorial Sloan Kettering Cancer Center
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Gary E. Deng, MD, PhD – Memorial Sloan Kettering Cancer Center ### 1699641###Speaker###Medical Director, Integrative Medicine Service###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
### 4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
4:45 PM – 5:20 PM ET
14 - Session 14: The Power of Patient Advocacy
4:45 PM – 5:20 PM ET
Session 14: The Power of Patient AdvocacyPresenter: – Fight Colorectal Cancer
Anjee Davis, MPPA (she/her/hers) – Fight Colorectal Cancer ### 1867780###Presenter###President###Fight Colorectal Cancer###Presenter: – Fight Colorectal Cancer
### she/her/hers5:20 PM – 5:30 PM ET
14 - Live Q&A
5:20 PM – 5:30 PM ET
Live Q&AModerator: – Vanderbilt-Ingram Cancer Center
Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Speaker: – Fight Colorectal Cancer
Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center ### 697457###Moderator###David H. Johnson Endowed Chair in Surgical and Medical Oncology, Co-Director, GI Oncology, Co-Leader, Gastrointestinal Cancer Research Program###Vanderbilt-Ingram Cancer Center###Moderator: – Vanderbilt-Ingram Cancer Center
### @@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###Moderator: – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
### @@@ Anjee Davis, MPPA (she/her/hers) – Fight Colorectal Cancer ### 1867780###Speaker###President###Fight Colorectal Cancer###Speaker: – Fight Colorectal Cancer
### she/her/hers